Aspen Aerogels experienced a challenging second quarter in 2025 with total revenue of $78.0 million, a decrease from the prior year. Despite a net loss of $9.1 million, the company showed significant improvement in gross margins at 32% and nearly doubled its Adjusted EBITDA quarter-over-quarter to $9.7 million, driven by cost structure reductions and strategic streamlining efforts.
Total revenue for Q2 2025 was $78.0 million, a decrease from $117.8 million in Q2 2024.
The company reported a net loss of $9.1 million, which included $5.9 million in restructuring and impairment charges.
Gross margins improved to 32% in Q2 2025, a three-percentage point increase quarter-over-quarter.
Adjusted EBITDA for Q2 2025 was $9.7 million, a 98% improvement quarter-over-quarter.
Aspen Aerogels anticipates maintaining a net cash position through year-end, driven by a leaner fixed cost structure and continued reductions in net working capital. The company expects significantly higher Adjusted EBITDA in the second half of 2025 on revenue levels consistent with the first half.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance